FDA Issues Comprehensive Draft Guidance for Developers of Artificial Intelligence-Enabled …

Today, the U.S. Food and Drug Administration issued draft guidance that includes recommendations to support development and marketing of safe and effective AI-enabled devices throughout the device’s Total Product Life Cycle. The guidance, if finalized, would be the first guidance to provide comprehensive recommendations for AI-enabled devices throughout the total product lifecycle, providing developers an accessible set of considerations that tie together design, development, maintenance and […]
FDA Issues Comprehensive Draft Guidance for Developers of Artificial Intelligence-Enabled …